Back to blog

Fluorescent and biotin labelling of research peptides: techniques and considerations

Why researchers label peptides

In many research set-ups it is not enough to know that a peptide engages in a particular interaction — one also wants to follow, quantify or visualise that interaction. For that, a peptide is often coupled to a fluorescent dye or to biotin, a small molecule that binds streptavidin with high affinity. These labelling techniques form the basis of countless in vitro assays, from binding studies to imaging research at cell culture level. This article gives an overview of the common labels, the chemistry behind them and the practical considerations in working with labelled research peptides.

Fluorescent labels: FITC and related dyes

Fluorescein isothiocyanate (FITC) is one of the most widely used fluorescent labels in peptide research, above all because of its low cost and the broad availability of detection equipment matched to its excitation and emission spectrum. FITC reacts mainly with primary amines — such as the N-terminus of a peptide or the side chain of lysine — via a thiourea bond. Alternative labels such as TAMRA, Cy3 or Cy5 are often chosen where a different wavelength range is needed, for example to avoid spectral overlap with other fluorophores in a multiplex set-up, or where photostability matters more than it does with FITC.

An important consideration in fluorescent labelling is the position of coupling. Labelling at the N-terminus usually disturbs the functional core of a peptide less than labelling on an internal side chain, but this depends heavily on the specific sequence and the role of that side chain in the interaction of interest. The literature therefore often recommends comparing several labelling positions where possible, before a labelled peptide is taken as representative of the unlabelled molecule.

Biotin-streptavidin: a non-fluorescent but powerful coupling

Alongside fluorescent labels, biotin is widely used as a functional tag. The affinity between biotin and streptavidin is among the strongest non-covalent interactions known in biochemistry, which makes biotinylation particularly suitable for assays in which a peptide has to be immobilised on a surface — in ELISA-like set-ups, affinity chromatography or surface plasmon resonance, for example. Biotin is usually coupled via a spacer arm, such as an aminohexanoic acid or PEG linker, to minimise steric hindrance between the peptide and the streptavidin surface.

Combinations such as FITC-PEG-biotin, uniting a fluorescent and an affinity function in one molecule, are used in set-ups requiring both visual detection and fixed coupling. The choice and length of the PEG spacer affects both the solubility of the labelled peptide and the accessibility of the biotin motif to streptavidin.

Effects of labelling on peptide properties

Adding a label is never chemically neutral. Fluorescent dyes such as FITC are relatively large, aromatic structures that can change the polarity and solubility of a peptide, and in some cases promote aggregation. Researchers therefore ideally document not only the sequence of the labelled peptide, but also the label, the coupling position and any changes in retention time on HPLC analysis relative to the unlabelled equivalent. Mass spectrometry is often used to confirm that the labelling reaction has run completely and specifically, since incomplete labelling can produce a mixture of labelled and unlabelled material that complicates the interpretation of assay results.

Photostability is another point of attention: FITC-conjugated peptides are relatively prone to photobleaching on prolonged exposure to light, which means storage and handling preferably take place in darkened or shielded conditions to limit signal loss during later measurements.

Documentation and quality control for labelled peptides

Because a label changes the physicochemical properties of a peptide, it is usual to characterise labelled batches separately from the unlabelled precursor. A certificate of analysis for a labelled peptide ideally contains both the mass and purity data of the end product and a statement of the labelling efficiency, so that researchers know what percentage of the material actually carries the intended label. This extra characterisation step is one of the reasons labelled peptides generally have a longer lead time and stricter documentation requirements than their unlabelled counterparts.

In closing

Fluorescent and biotin labelling are among the most widely used techniques for making peptide interactions visible and measurable in laboratory research. The choice of label, the coupling chemistry and the position on the peptide all influence the usability of the end product, and careful characterisation remains essential for safeguarding reliable research results.

These products and information are intended solely for laboratory and research purposes. Not intended for human or animal consumption, diagnostic use or therapeutic application.